Implications of Medical and Recreational Marijuana Laws for Neuroscience Research: a Review.
Cannabis potency
Cannabis use disorder
Medical marijuana laws
Neurocognitive impairments
Recreational marijuana laws
Journal
Current behavioral neuroscience reports
ISSN: 2196-2979
Titre abrégé: Curr Behav Neurosci Rep
Pays: Switzerland
ID NLM: 101626570
Informations de publication
Date de publication:
Dec 2020
Dec 2020
Historique:
entrez:
2
8
2021
pubmed:
3
8
2021
medline:
3
8
2021
Statut:
ppublish
Résumé
Review of US medical and recreational marijuana laws (MML and RML), their effects on cannabis potency, prevalence of non-medical cannabis use and cannabis use disorder (CUD) in adolescents and adults, and implications for neuroscience research, given what is known about the relationship of cannabis to neurocognitive impairments and underlying brain functioning. Cannabis potency may be increasing faster in states with MML or RML than in other states. MML and RML have not impacted prevalence in adolescents but have consistently been shown to increase rates of adult non-medical use and CUD. Recent neurocognitive or neuroimaging studies may be more impacted by cannabis than studies conducted when MML and RML were less common. Neurocognitive or neuroimaging studies conducted in MML or RML states should carefully test potential participants for recent cannabis use. More research is needed on cannabis and cognition in medical marijuana patients.
Identifiants
pubmed: 34336547
doi: 10.1007/s40473-020-00222-5
pmc: PMC8323790
mid: NIHMS1680267
doi:
Types de publication
Journal Article
Langues
eng
Pagination
258-266Subventions
Organisme : NIDA NIH HHS
ID : R01 DA048860
Pays : United States
Références
Curr Drug Abuse Rev. 2008 Jan;1(1):81-98
pubmed: 19630708
Ann N Y Acad Sci. 2019 Sep;1451(1):42-70
pubmed: 30426517
JAMA Netw Open. 2020 Apr 1;3(4):e202370
pubmed: 32271390
Arch Clin Neuropsychol. 2019 Jul 26;34(5):700-705
pubmed: 30295694
Soc Psychiatry Psychiatr Epidemiol. 2015 Feb;50(2):171-82
pubmed: 25563838
J Int Neuropsychol Soc. 2007 Sep;13(5):807-20
pubmed: 17697412
Curr Top Behav Neurosci. 2020;47:93-112
pubmed: 31845132
Int J Drug Policy. 2013 Nov;24(6):511-6
pubmed: 24095000
Sci Am. 1991 Jul;265(1):40-7
pubmed: 1882226
Curr Top Behav Neurosci. 2017;34:173-198
pubmed: 26718590
Arch Gen Psychiatry. 1999 Oct;56(10):921-6
pubmed: 10530634
JAMA Pediatr. 2020 Jan 1;174(1):98-99
pubmed: 31710355
JAMA. 2017 Jan 10;317(2):209-211
pubmed: 27992636
J Stud Alcohol Drugs. 2020 Mar;81(2):164-172
pubmed: 32359045
JAMA Pediatr. 2020 Jan 1;174(1):99
pubmed: 31710353
J Abnorm Psychol. 2003 Aug;112(3):437-47
pubmed: 12943022
Am J Drug Alcohol Abuse. 2019;45(6):563-579
pubmed: 31365275
Biol Psychiatry. 2016 Apr 1;79(7):557-67
pubmed: 26858214
Drug Alcohol Depend. 2012 Jan 1;120(1-3):22-7
pubmed: 22099393
J Health Econ. 2015 Jul;42:64-80
pubmed: 25863001
Adv Psychosom Med. 2004;25:63-77
pubmed: 15248367
Neuropsychol Rev. 2016 Jun;26(2):186-222
pubmed: 27125202
Lancet Psychiatry. 2016 Oct;3(10):954-964
pubmed: 27592339
Addict Behav. 2017 Sep;72:14-20
pubmed: 28340421
Addict Behav. 2020 Sep;108:106437
pubmed: 32330763
Eur Arch Psychiatry Clin Neurosci. 2019 Feb;269(1):59-71
pubmed: 30706169
Brain Sci. 2020 Feb 13;10(2):
pubmed: 32069958
PLoS One. 2020 Mar 26;15(3):e0230167
pubmed: 32214334
Ann Epidemiol. 2011 Sep;21(9):714-6
pubmed: 21820632
Addiction. 2017 Nov;112(11):1985-1991
pubmed: 28600874
Proc Natl Acad Sci U S A. 2007 Jun 5;104(23):9800-5
pubmed: 17535893
Health Aff (Millwood). 2016 Mar;35(3):480-8
pubmed: 26953303
Addiction. 2018 Jun;113(6):1003-1016
pubmed: 29468763
Brain Imaging Behav. 2016 Dec;10(4):1254-1263
pubmed: 26667034
Lancet Psychiatry. 2015 Jul;2(7):601-8
pubmed: 26303557
J Abnorm Child Psychol. 2012 Apr;40(3):459-70
pubmed: 21932056
Harm Reduct J. 2007 Nov 03;4:16
pubmed: 17980043
JAMA Pediatr. 2019 Sep 1;173(9):879-881
pubmed: 31282944
JAMA Psychiatry. 2018 Jun 1;75(6):585-595
pubmed: 29710074
J Adolesc Health. 2019 Apr;64(4):487-493
pubmed: 30205931
Neuropsychopharmacology. 2018 Jan;43(1):195-212
pubmed: 28853439
Psychol Med. 2020 Jul;50(9):1530-1538
pubmed: 31258104
Drug Alcohol Depend. 2016 Dec 01;169:26-32
pubmed: 27755989
Curr Pharm Des. 2014;20(13):2126-37
pubmed: 23829358
JAMA Pediatr. 2020 Jan 1;174(1):97-98
pubmed: 31710354
Int J Drug Policy. 2014 May;25(3):424-35
pubmed: 24589410
Proc Natl Acad Sci U S A. 2012 Oct 2;109(40):E2657-64
pubmed: 22927402
Curr Drug Abuse Rev. 2008 Jan;1(1):99-111
pubmed: 19630709
JAMA Psychiatry. 2017 Jun 1;74(6):579-588
pubmed: 28445557
J Psychoactive Drugs. 2011 Apr-Jun;43(2):128-35
pubmed: 21858958
Eur Arch Psychiatry Clin Neurosci. 2019 Feb;269(1):37-58
pubmed: 30680487
Int J Drug Policy. 2014 Mar;25(2):308-19
pubmed: 24502887
Addict Behav. 2010 Nov;35(11):970-6
pubmed: 20621421
Addiction. 2016 Oct;111(10):1764-73
pubmed: 27082374
Psychol Med. 2013 Aug;43(8):1673-83
pubmed: 23171498
J Health Econ. 2014 Dec;38:43-61
pubmed: 25205609
JAMA Psychiatry. 2020 Feb 1;77(2):165-171
pubmed: 31722000
Arch Gen Psychiatry. 2011 Oct;68(10):1003-11
pubmed: 21969458
JAMA Pediatr. 2020 Jan 1;174(1):96-97
pubmed: 31710351
Addiction. 2020 Oct;115(10):1944-1953
pubmed: 32141142
Neurosci Biobehav Rev. 2016 May;64:359-81
pubmed: 26987641
J Addict Dis. 2000;19(3):89-103
pubmed: 11076122
J Addict Med. 2011 Mar;5(1):1-8
pubmed: 21321675
Drug Alcohol Depend. 2017 Aug 1;177:299-306
pubmed: 28662974
Drug Alcohol Depend. 2018 May 1;186:68-74
pubmed: 29550624
J Policy Anal Manage. 2015 Winter;34(1):7-31
pubmed: 25558490
Nature. 2016 Nov 16;539(7629):369-377
pubmed: 27853201
Prev Med. 2016 Sep;90:114-20
pubmed: 27373208
Prev Med. 2017 Nov;104:24-30
pubmed: 28365373
Addiction. 2016 Dec;111(12):2187-2195
pubmed: 27393902
Prev Med. 2017 Jun;99:80-86
pubmed: 28189806
Nat Neurosci. 2020 May;23(5):600-610
pubmed: 32251385
Int Rev Psychiatry. 2018 Jun;30(3):251-267
pubmed: 29966459
Addiction. 2017 Dec;112(12):2132-2143
pubmed: 28623859